Compounds > androstane-3,17-diol
Page last updated: 2024-08-23

androstane-3,17-diol and Adenocarcinoma

androstane-3,17-diol has been researched along with Adenocarcinoma in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19904 (44.44)18.7374
1990's1 (11.11)18.2507
2000's4 (44.44)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauman, DR; Lin, HK; Peehl, DM; Penning, TM; Rizner, TL; Steckelbroeck, S1
Bélanger, A; Guillemette, C; Hum, DW1
Adams, JY; Alroy, J; Leav, I; Merk, FB; Schelling, KH2
Bonafe, M; Dallapiccola, B; De Luca, A; Franceschi, C; Froio, F; Margiotti, K; Micali, F; Novelli, G; Pearce, CL; Reichardt, JK; Ricci-Barbini, V; Sangiuolo, F1
Miller, WR2
Bongini, M; Bozzolan, F; Doukani, A; Mauvais-Jarvis, P; Poizat, R; Wright, F1
Bélanger, A; Brochu, M; Cusan, L; Dupont, A; Labrie, F1

Other Studies

9 other study(ies) available for androstane-3,17-diol and Adenocarcinoma

ArticleYear
Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.
    Endocrinology, 2003, Volume: 144, Issue:7

    Topics: 17-Hydroxysteroid Dehydrogenases; Adenocarcinoma; Androstane-3,17-diol; Animals; Bone Neoplasms; COS Cells; Dihydrotestosterone; Epithelial Cells; Gene Expression Regulation, Enzymologic; Humans; Hydroxysteroid Dehydrogenases; In Vitro Techniques; Isoenzymes; Male; Prostate; Prostatic Neoplasms; Testosterone; Tumor Cells, Cultured

2003
Specificity of glucuronosyltransferase activity in the human cancer cell line LNCaP, evidence for the presence of at least two glucuronosyltransferase enzymes.
    The Journal of steroid biochemistry and molecular biology, 1995, Volume: 55, Issue:3-4

    Topics: Adenocarcinoma; Androstane-3,17-diol; Androsterone; Binding, Competitive; Dihydrotestosterone; Estradiol; Estriol; Estrone; Glucuronosyltransferase; Humans; Kinetics; Male; Prostatic Neoplasms; Substrate Specificity; Testosterone; Tumor Cells, Cultured

1995
Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    The Prostate, 2001, May-15, Volume: 47, Issue:3

    Topics: Adenocarcinoma; Androstane-3,17-diol; Animals; Cell Division; Dihydrotestosterone; Disease Models, Animal; Dog Diseases; Dogs; Estradiol; Gonadal Steroid Hormones; Immunohistochemistry; Keratins; Ki-67 Antigen; Male; Orchiectomy; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen

2001
Evidence for an association between the SRD5A2 (type II steroid 5 alpha-reductase) locus and prostate cancer in Italian patients.
    Disease markers, 2000, Volume: 16, Issue:3-4

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adenocarcinoma; Aged; Aged, 80 and over; Amino Acid Substitution; Androstane-3,17-diol; Codon; Dinucleotide Repeats; Ethnicity; Gene Frequency; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Italy; Male; Middle Aged; Mutation, Missense; Neoplasm Proteins; Polymorphism, Genetic; Prostatic Neoplasms; Risk

2000
Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    The Prostate, 2001, Aug-01, Volume: 48, Issue:3

    Topics: Adenocarcinoma; Androstane-3,17-diol; Animals; Cell Division; Dihydrotestosterone; Disease Models, Animal; Dog Diseases; Dogs; Estradiol; Gonadal Steroid Hormones; Immunohistochemistry; Keratins; Ki-67 Antigen; Male; Orchiectomy; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen

2001
Hyperprolactinemia and steroid metabolism by rat mammary adenocarcinomas.
    Cancer research, 1976, Volume: 36, Issue:2 Pt 1

    Topics: Adenocarcinoma; Androstane-3,17-diol; Animals; Dehydroepiandrosterone; DNA, Neoplasm; Female; In Vitro Techniques; Mammary Neoplasms, Experimental; Prolactin; Rats; Testosterone

1976
In vitro effects of prolactin upon testosterone metabolism by rat mammary adenocarcinomata.
    European journal of cancer, 1976, Volume: 12, Issue:9

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Androstane-3,17-diol; Animals; Dihydrotestosterone; Female; In Vitro Techniques; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Prolactin; Rats; Testosterone; Thymectomy; Transplantation, Isogeneic

1976
Decreased urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide excretion in patients with benign prostatic hyperplasia.
    The Journal of clinical endocrinology and metabolism, 1985, Volume: 60, Issue:2

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aging; Androstane-3,17-diol; Androstanols; Androstenedione; Dihydrotestosterone; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone

1985
Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
    Clinical and investigative medicine. Medecine clinique et experimentale, 1988, Volume: 11, Issue:5

    Topics: Adenocarcinoma; Adrenal Cortex Hormones; Androgens; Androstane-3,17-diol; Androstenediol; Androstenedione; Androsterone; Anilides; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dehydroepiandrosterone; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hydrocortisone; Kinetics; Luteinizing Hormone; Male; Pregnenolone; Progesterone; Prolactin; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate

1988